194 related articles for article (PubMed ID: 19876698)
1. The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
Cervellini I; Bello E; Frapolli R; Porretta-Serapiglia C; Oggioni N; Canta A; Lombardi R; Camozzi F; Roglio I; Melcangi RC; D'incalci M; Lauria G; Ghezzi P; Cavaletti G; Bianchi R
Neurotox Res; 2010 Aug; 18(2):151-60. PubMed ID: 19876698
[TBL] [Abstract][Full Text] [Related]
2. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
Maggioni D; Nicolini G; Chiorazzi A; Meregalli C; Cavaletti G; Tredici G
J Neurosci Res; 2010 Nov; 88(14):3171-9. PubMed ID: 20722073
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth.
Bianchi R; Gilardini A; Rodriguez-Menendez V; Oggioni N; Canta A; Colombo T; De Michele G; Martone S; Sfacteria A; Piedemonte G; Grasso G; Beccaglia P; Ghezzi P; D'Incalci M; Lauria G; Cavaletti G
Eur J Cancer; 2007 Mar; 43(4):710-7. PubMed ID: 17251006
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
Roglio I; Bianchi R; Camozzi F; Carozzi V; Cervellini I; Crippa D; Lauria G; Cavaletti G; Melcangi RC
J Peripher Nerv Syst; 2009 Mar; 14(1):36-44. PubMed ID: 19335538
[TBL] [Abstract][Full Text] [Related]
6. Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy.
Kassem LA; Yassin NA
Pak J Biol Sci; 2010 Jun; 13(12):577-87. PubMed ID: 21061908
[TBL] [Abstract][Full Text] [Related]
7. A neuroprotective derivative of erythropoietin that is not erythropoietic.
Doggrell SA
Expert Opin Investig Drugs; 2004 Nov; 13(11):1517-9. PubMed ID: 15500399
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.
Ghirardi O; Lo Giudice P; Pisano C; Vertechy M; Bellucci A; Vesci L; Cundari S; Miloso M; Rigamonti LM; Nicolini G; Zanna C; Carminati P
Anticancer Res; 2005; 25(4):2681-7. PubMed ID: 16080512
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
Callizot N; Andriambeloson E; Glass J; Revel M; Ferro P; Cirillo R; Vitte PA; Dreano M
Cancer Chemother Pharmacol; 2008 Nov; 62(6):995-1007. PubMed ID: 18270703
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylcholine attenuated docetaxel-induced peripheral neurotoxicity in rats.
Kim ST; Kyung EJ; Suh JS; Lee HS; Lee JH; Chae SI; Park ES; Chung YH; Bae J; Lee TJ; Lee WM; Sohn UD; Jeong JH
Drug Chem Toxicol; 2018 Oct; 41(4):476-485. PubMed ID: 29210293
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model.
Sharawy N; Rashed L; Youakim MF
Exp Toxicol Pathol; 2015 Apr; 67(4):315-22. PubMed ID: 25758589
[TBL] [Abstract][Full Text] [Related]
12. Peripheral nerve damage associated with administration of taxanes in patients with cancer.
Argyriou AA; Koltzenburg M; Polychronopoulos P; Papapetropoulos S; Kalofonos HP
Crit Rev Oncol Hematol; 2008 Jun; 66(3):218-28. PubMed ID: 18329278
[TBL] [Abstract][Full Text] [Related]
13. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats.
Orhan B; Yalcin S; Nurlu G; Zeybek D; Muftuoglu S
Med Oncol; 2004; 21(2):197-203. PubMed ID: 15299192
[TBL] [Abstract][Full Text] [Related]
15. Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats.
Persohn E; Canta A; Schoepfer S; Traebert M; Mueller L; Gilardini A; Galbiati S; Nicolini G; Scuteri A; Lanzani F; Giussani G; Cavaletti G
Eur J Cancer; 2005 Jul; 41(10):1460-6. PubMed ID: 15913989
[TBL] [Abstract][Full Text] [Related]
16. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
17. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
18. Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity.
Zhu J; Carozzi VA; Reed N; Mi R; Marmiroli P; Cavaletti G; Hoke A
Sci Rep; 2016 Jun; 6():28861. PubMed ID: 27350330
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of doxorubicin in combination with docetaxel against human breast cancer xenografts.
Egawa T; Kubota T; Suto A; Otani Y; Furukawa T; Saikawa Y; Watanabe M; Kumai K; Kitajima M
In Vivo; 2003; 17(1):23-8. PubMed ID: 12655785
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.
Yoo JY; Won YJ; Lee JH; Kim JU; Sung IY; Hwang SJ; Kim MJ; Hong HN
J Neurosci Res; 2009 Jan; 87(1):150-63. PubMed ID: 18711747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
